Public Health Foundation Enterprises, Inc.

Public Health Foundation Enterprises, Inc., doing business as Heluna Health, is a California-based nonprofit research and fiscal intermediary organization that acts as both a prime recipient and subrecipient on federal research grants and cooperative agreements, with roughly balanced split between prime (49% of recent awards, 147 total) and sub roles (51%, 150 total). The organization holds a GSA Multiple Award Schedule contract with labor categories spanning administrative, project management, data management, and human resources roles priced from $47.29 to $90.17 per hour, with no security clearance positions.

Heluna Health's federal footprint is heavily concentrated in public health research and implementation, particularly HIV prevention, substance use interventions, maternal health equity, and infectious disease surveillance. Recent prime grant awards include a $610,601 National Institute of Mental Health (NIMH) grant under the Mental Health Research Grants program (CFDA 93.242) to conduct an effectiveness-implementation hybrid study of PrEP and DoxPEP uptake strategies integrated into the TakemeHome.org home HIV/STI self-testing platform across four high-prevalence jurisdictions, running through June 2031; a $1.177 million National Institute on Drug Abuse (NIDA) award under Drug Use and Addiction Research Programs (CFDA 93.279) testing the Street Prep low-barrier HIV PrEP delivery model for people who use drugs and experience homelessness in San Francisco through January 2031; and a $659,242 NIMH grant to develop and evaluate the PrEP Blueprint implementation toolkit for scaling PrEP access across multiple delivery modalities, completing November 2030. Additional prime awards include a $3.122 million NIDA grant for a randomized-controlled trial of B-SAFE, a behavioral intervention addressing unintentional fentanyl use among stimulant users (through May 2030), and smaller grants from USDA's National Institute of Food and Agriculture ($299,547, examining WIC vendor access and child diet quality through August 2027), the National Park Service ($299 thousand, evaluating rodent-borne disease risk at Lassen Volcanic and Yosemite parks), and the Fogarty International Center (multi-level HIV stigma reduction intervention with trans women in Nepal). Heluna Health also holds a cooperative agreement with CDC's National Center for HIV/AIDS for technical assistance delivery to health departments and community-based organizations addressing social determinants of health in HIV prevention, and a five-year partnership with the California Department of Public Health for infectious disease surveillance and emergency response capacity building.

Customer concentration is pronounced but split across grantor agencies. By award count, the Department of Agriculture Food and Nutrition Service dominates with 48 awards; the Department of Health and Human Services Centers for Disease Control and Prevention follows with 31 awards; and the National Institute on Drug Abuse accounts for 26 awards. These three entities represent 49% of all awards. By potential dollar value, CDC Pittsburgh carries the largest concentration at $40 million across four awards, followed by CDC's Office of Acquisition Services with $16.7 million across 12 awards. The combined potential value across all 297 recent awards sits at $66.6 million, though obligated dollars ($5.12 billion) substantially exceed potential value, reflecting the nature of grant accounting where multi-year awards accrue obligations across fiscal years.

Heluna Health subcontracts to other prime recipients far more frequently than it primes federal contracts directly. The source identifies the organization as a subrecipient under grants held by the California Department of Public Health (recurring subawards under the WIC program, CFDA 10.557, and immunization and infectious disease initiatives), the University of California San Francisco (numerous research subawards spanning HIV prevention, substance use treatment, and training infrastructure), the Regents of the University of California system, the Los Angeles County Department of Public Health (HIV prevention and emergency relief programs), Research Triangle Institute (TB drug susceptibility testing and surveillance projects), the Association of Public Health Laboratories (influenza reference center and vaccine preventable disease services), and academic institutions including Emory University, Harvard Pilgrim Health Care, and the University of Miami. The organization's sub role centers on research administration, fiscal intermediary services, personnel recruitment and payroll management, data collection and management, and clinical or training staff support. Across SCI-reportable service contracts, Heluna Health shows minimal scale, with only 3 records spanning FY2022–FY2025 (all as named subcontractor, zero as prime), representing roughly 0.3 FTEs in FY2022 and 0.0 FTEs in FY2025 — a reflection that SCI captures a narrow slice (service contracts above $150,000) and excludes grant and cooperative agreement work that dominates the organization's federal portfolio.

Activity trajectory shows accelerating growth: seven awards in 2022, thirty-two in 2023, forty-nine in 2024, fifty-four in 2025, and twenty-one in 2026 through late August. Eight awards carry ultimate completion dates within the next twenty-four months and face recompete risk. The organization's role as a nonprofit fiscal intermediary — serving over 250 programs with combined budgets exceeding $120 million as stated in several subaward descriptions — positions it as an administrative backbone for California-based public health research and implementation networks, particularly within the HIV/STI, substance use treatment, maternal health equity, and infectious disease surveillance ecosystems centered on the West Coast and increasingly leveraging UCSF as a lead research institution.